The Fact About ABBV-744 in combination with immunotherapy That No One Is Suggesting
In Section C, participants will acquire ABBV-744 and oral navitoclax. In Segment D, members will acquire ABBV-744 and ruxolitinib. Individuals will get treatment until finally illness progression or maybe the participants are not able to tolerate the study drugs.and after that boost H3K27Ac at this location. Chromatin hyperacetylation could boost t